SCHEMBL21547046

SCHEMBL21547046

N#Cc1cccc(-c2cc(-n3c4ccccc4c4cc(-c5cccc(-c6ccccc6)n5)ccc43)c(C(F)(F)F)c(-n3c4ccccc4c4cc(-c5cccc(-c6ccccc6)n5)ccc43)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.42
PDK2 Q15119 1/20 0.39
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 3/20 0.38
GABRA3 P34903 3/20 0.38
GABRA1 P14867 1/20 0.38
PTPN5 P54829 1/20 0.36
ADORA2A P29274 1/20 0.36
GRM2 Q14416 1/20 0.36
CTSS P25774 1/20 0.36
ENPP1 P22413 1/20 0.36
IDO1 P14902 1/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21547014 0.97 ALDH1A3 (0.44) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL22761025 0.94 ALDH1A3 (0.42) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL22562254 0.94 ALDH1A3 (0.38) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL22562274 0.92 MYC (0.40) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL22562326 0.91 ALDH1A3 (0.39) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL21547044 0.91 ALDH1A3 (0.44) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL22562443 0.91 ABCB1 (0.37) ALDH1A3GABRG2GABRB3GABRA5GABRA3
SCHEMBL22760671 0.91 PTPN5 (0.44) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL22761174 0.91 PTPN5 (0.43) ALDH1A3PDK2GABRG2GABRB3GABRA5
SCHEMBL21546869 0.89 PTPN5 (0.41) ALDH1A3PDK2GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981930-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-20 US disclosed
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-10 US disclosed
EP-3478793-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981930-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, EPCAM ALDH1A3 39/4885PDK2 2517/4885GABRG2 1767/4885
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, EPCAM ALDH1A3 39/4885PDK2 2517/4885GABRG2 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.